SYNTHESIS AND ADENOSINE RECEPTOR AFFINITY OF A SERIES OF PYRAZOLO[3,4-D]PYRIMIDINE ANALOGS OF 1-METHYLISOGUANOSINE

被引:40
作者
HARDEN, FA [1 ]
QUINN, RJ [1 ]
SCAMMELLS, PJ [1 ]
机构
[1] GRIFFITH UNIV,DIV SCI & TECHNOL,NATHAN,QLD 4111,AUSTRALIA
关键词
D O I
10.1021/jm00113a031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrazolo[3,4-d]pyrimidines are pyrazolo analogues of purines. They have been shown to be a general class of compounds which exhibit A1 adenosine receptor affinity. Two series of pyrazolo[3,4-d]pyrimidine analogues of 1-methylisoguanosine have been synthesized. The first involved substitution of the N1-position while the second involved substitution of the N5-position. Both alkyl and aryl substituents were examined. All compounds were tested for A1 adenosine receptor affinity by using a (R)-[H-3]-N6-(phenylisopropyl)adenosine binding assay. The 3-chlorophenyl group showed the greatest activity in the N1-position and the butyl group produced the greatest activity in the N5-position. Combination of the best substituent in each of these positions enhanced the overall activity. The most potent compound was 4-amino-5-N-butyl-1-(3-chlorophenyl)-H-1-pyrazolo[3,4-d]pyrimidin-6(H-5)-one with an IC50 of 6.4 x 10(-6) M. Selectivity at the receptor subclasses was examined by performing an A2 adenosine receptor affinity assay with [H-3]CGS 21680. This series of compounds were slightly less potent at A2 receptors. 4-Amino-5-N-butyl-1-(3-chlorophenyl)H-1-pyrazolo[3,4-d]pyrimidin-6(H-5)-one was the most potent compound with an IC50 of 19.2 x 10(-6) M.
引用
收藏
页码:2892 / 2898
页数:7
相关论文
共 26 条
[1]   1-METHYLISOGUANOSINE - ORALLY ACTIVE MARINE NATURAL PRODUCT WITH SKELETAL-MUSCLE AND CARDIOVASCULAR EFFECTS [J].
BAIRDLAMBERT, J ;
MARWOOD, JF ;
DAVIES, LP ;
TAYLOR, KM .
LIFE SCIENCES, 1980, 26 (13) :1069-1077
[2]   DEHYDROGENATION OF TETRAHYDROCARBAZOLES BY CHLORANIL [J].
BARCLAY, BM ;
CAMPBELL, N .
JOURNAL OF THE CHEMICAL SOCIETY, 1945, :530-533
[3]   SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A SERIES OF ANALOGS OF 1-METHYLISOGUANOSINE [J].
BARTLETT, RT ;
COOK, AF ;
HOLMAN, MJ ;
MCCOMAS, WW ;
NOWOSWAIT, EF ;
POONIAN, MS ;
BAIRDLAMBERT, JA ;
BALDO, BA ;
MARWOOD, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (08) :947-954
[4]   POTENTIAL PURINE ANTAGONISTS .6. SYNTHESIS OF 1-ALKYL-4-SUBSTITUTED AND 1-ARYL-4-SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES [J].
CHENG, CC ;
ROBINS, RK .
JOURNAL OF ORGANIC CHEMISTRY, 1956, 21 (11) :1240-1256
[5]   A NOVEL AND EFFICIENT SYNTHESIS OF THE NATURALLY-OCCURRING NUCLEOSIDE DORIDOSINE [J].
CHERN, JW ;
TOWNSEND, LB .
TETRAHEDRON LETTERS, 1985, 26 (52) :6419-6422
[6]  
COLEMAN GH, ORG SYNTH, V1, P442
[7]   1-METHYLISOGUANOSINE, A PHARMACOLOGICALLY ACTIVE AGENT FROM A MARINE SPONGE [J].
COOK, AF ;
BARTLETT, RT ;
GREGSON, RP ;
QUINN, RJ .
JOURNAL OF ORGANIC CHEMISTRY, 1980, 45 (20) :4020-4025
[8]   7-DEAZA-9-PHENYLADENINES - A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS [J].
DALY, JW ;
PADGETT, WL ;
EGER, K .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (19) :3749-3753
[9]   PYRAZOLO[3,4-D]PYRIMIDINES, A NEW CLASS OF ADENOSINE ANTAGONISTS [J].
DAVIES, LP ;
BROWN, DJ ;
CHOW, SC ;
JOHNSTON, GAR .
NEUROSCIENCE LETTERS, 1983, 41 (1-2) :189-193
[10]   PYRAZOLO[3,4-D]PYRIMIDINES AS ADENOSINE ANTAGONISTS [J].
DAVIES, LP ;
CHOW, SC ;
SKERRITT, JH ;
BROWN, DJ ;
JOHNSTON, GAR .
LIFE SCIENCES, 1984, 34 (22) :2117-2128